Predictive Oncology Inc (POAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 4 | 3 | 110 | 1,548 | 4 |
| Cost of Goods | 8 | 18 | 45 | 779 | 11 |
| Gross Profit | -5 | -16 | 65 | 769 | -7 |
| Operating Expenses | 3,284 | 2,663 | 2,397 | 4,280 | 2,164 |
| Operating Income | -3,280 | -2,660 | -2,287 | -2,732 | -2,160 |
| Other Income | -74,367 | 681 | 2 | 23 | 31 |
| Pre-tax Income | -77,647 | -1,979 | -2,285 | -2,710 | -2,130 |
| Net Income Continuous | -77,647 | -1,979 | -2,285 | -2,710 | -2,130 |
| Net Income Discontinuous | -5 | -92 | -158 | 540 | -965 |
| Net Income | $-77,652 | $-2,071 | $-2,443 | $-2,170 | $-3,095 |
| EPS Basic Total Ops | -107.25 | -3.45 | -5.10 | -1.74 | -7.26 |
| EPS Basic Continuous Ops | -107.24 | -3.30 | -4.80 | -3.71 | -4.99 |
| EPS Basic Discontinuous Ops | -0.01 | -0.15 | -0.30 | 1.97 | -2.27 |
| EPS Diluted Total Ops | -107.25 | -3.45 | -5.10 | -1.74 | -7.26 |
| EPS Diluted Continuous Ops | -107.24 | -3.30 | -4.80 | -3.71 | -4.99 |
| EPS Diluted Discontinuous Ops | -0.01 | -0.15 | -0.30 | 1.97 | -2.27 |
| EPS Diluted Before Non-Recurring Items | -4.52 | -3.30 | -4.80 | N/A | -5.40 |
| EBITDA(a) | $-3,105 | $-2,490 | $-2,121 | $-2,503 | $-2,002 |